Bio-Rad Laboratories, Inc. Signs Two Multi-Year Agreements With Quest Diagnostics Inc.

HERCULES, CA--(MARKET WIRE)--Jul 17, 2007 -- Bio-Rad Laboratories (AMEX:BIO - News) and (AMEX:BIO-B - News), Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that the company has signed two multi-year agreements with Quest Diagnostics Incorporated (NYSE:DGX - News) to place BioPlex® 2200 systems and autoimmune test reagents as well as Bio-Rad’s HIV-1/HIV-2 PLUS O EIA assay, which allows Quest Diagnostics to detect HIV-1 and HIV-2 in their network of reference laboratories nationwide. Terms of the agreements were not disclosed.

MORE ON THIS TOPIC